Serum levels of pro-inflammatory cytokines including IL-17, IL-22, and IL-6 were even significantly higher in T2D patients compared with the MHO group, indicating an aggravated inflammatory status. The gene discussed is IL6; the disease is type 2 diabetes mellitus.